332 related articles for article (PubMed ID: 25897811)
41. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T
Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
[TBL] [Abstract][Full Text] [Related]
42. Beyond Members of the
Ferreira AC; Reis PA; de Freitas CS; Sacramento CQ; Villas Bôas Hoelz L; Bastos MM; Mattos M; Rocha N; Gomes de Azevedo Quintanilha I; da Silva Gouveia Pedrosa C; Rocha Quintino Souza L; Correia Loiola E; Trindade P; Rangel Vieira Y; Barbosa-Lima G; de Castro Faria Neto HC; Boechat N; Rehen SK; Brüning K; Bozza FA; Bozza PT; Souza TML
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455237
[TBL] [Abstract][Full Text] [Related]
43. Monoclonal antibody targeting chikungunya virus envelope 1 protein inhibits virus release.
Masrinoul P; Puiprom O; Tanaka A; Kuwahara M; Chaichana P; Ikuta K; Ramasoota P; Okabayashi T
Virology; 2014 Sep; 464-465():111-117. PubMed ID: 25063884
[TBL] [Abstract][Full Text] [Related]
44. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.
Delang L; Segura Guerrero N; Tas A; Quérat G; Pastorino B; Froeyen M; Dallmeier K; Jochmans D; Herdewijn P; Bello F; Snijder EJ; de Lamballerie X; Martina B; Neyts J; van Hemert MJ; Leyssen P
J Antimicrob Chemother; 2014 Oct; 69(10):2770-84. PubMed ID: 24951535
[TBL] [Abstract][Full Text] [Related]
45. 51 years in of Chikungunya clinical vaccine development: A historical perspective.
Reyes-Sandoval A
Hum Vaccin Immunother; 2019; 15(10):2351-2358. PubMed ID: 30735447
[TBL] [Abstract][Full Text] [Related]
46. Infectious RNA vaccine protects mice against chikungunya virus infection.
Szurgot I; Ljungberg K; Kümmerer BM; Liljeström P
Sci Rep; 2020 Dec; 10(1):21076. PubMed ID: 33273501
[TBL] [Abstract][Full Text] [Related]
47. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.
Brandler S; Ruffié C; Combredet C; Brault JB; Najburg V; Prevost MC; Habel A; Tauber E; Desprès P; Tangy F
Vaccine; 2013 Aug; 31(36):3718-25. PubMed ID: 23742993
[TBL] [Abstract][Full Text] [Related]
48. Control of immunopathology during chikungunya virus infection.
Petitdemange C; Wauquier N; Vieillard V
J Allergy Clin Immunol; 2015 Apr; 135(4):846-855. PubMed ID: 25843597
[TBL] [Abstract][Full Text] [Related]
49. Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence.
Lorente E; Barriga A; Barnea E; Palomo C; García-Arriaza J; Mir C; Esteban M; Admon A; López D
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007547. PubMed ID: 31276466
[TBL] [Abstract][Full Text] [Related]
50. Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus.
López-Camacho C; Kim YC; Blight J; Lazaro Moreli M; Montoya-Diaz E; Huiskonen JT; Kümmerer BM; Reyes-Sandoval A
Viruses; 2019 Apr; 11(4):. PubMed ID: 30987160
[TBL] [Abstract][Full Text] [Related]
51. Chikungunya: international focus issue.
Roques P; Ng LF; Sam IC; Higgs S
Vector Borne Zoonotic Dis; 2015 Apr; 15(4):221-2. PubMed ID: 25897808
[No Abstract] [Full Text] [Related]
52. Chikungunya vaccines in development.
Schwameis M; Buchtele N; Wadowski PP; Schoergenhofer C; Jilma B
Hum Vaccin Immunother; 2016 Mar; 12(3):716-31. PubMed ID: 26554522
[TBL] [Abstract][Full Text] [Related]
53. Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus.
Muthumani K; Block P; Flingai S; Muruganantham N; Chaaithanya IK; Tingey C; Wise M; Reuschel EL; Chung C; Muthumani A; Sarangan G; Srikanth P; Khan AS; Vijayachari P; Sardesai NY; Kim JJ; Ugen KE; Weiner DB
J Infect Dis; 2016 Aug; 214(3):369-78. PubMed ID: 27001960
[TBL] [Abstract][Full Text] [Related]
54. Amid Paraguay Chikungunya Outbreak, Vaccine Candidate Safe, Immunogenic.
Harris E
JAMA; 2023 Jul; 330(2):111. PubMed ID: 37342059
[No Abstract] [Full Text] [Related]
55. A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses.
Prow NA; Liu L; Nakayama E; Cooper TH; Yan K; Eldi P; Hazlewood JE; Tang B; Le TT; Setoh YX; Khromykh AA; Hobson-Peters J; Diener KR; Howley PM; Hayball JD; Suhrbier A
Nat Commun; 2018 Mar; 9(1):1230. PubMed ID: 29581442
[TBL] [Abstract][Full Text] [Related]
56. Development of novel antibodies against non-structural proteins nsP1, nsP3 and nsP4 of chikungunya virus: potential use in basic research.
Kumar S; Mamidi P; Kumar A; Basantray I; Bramha U; Dixit A; Maiti PK; Singh S; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
Arch Virol; 2015 Nov; 160(11):2749-61. PubMed ID: 26280524
[TBL] [Abstract][Full Text] [Related]
57. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies.
Venceslau-Carvalho AA; Teixeira de Pinho Favaro M; Ramos Pereira L; Rodrigues-Jesus MJ; Santos Pereira S; Andreata-Santos R; Dos Santos Alves RP; Castro-Amarante MF; Bitencourt Rodrigues K; Ramos da Silva J; Rahal Guaragna Machado R; Dos Passos Cunha M; Marinho de Andrade Zanotto P; Luzetti Fotoran W; Wunderlich G; Durigon EL; de Souza Ferreira LC
Nanomedicine; 2021 Oct; 37():102445. PubMed ID: 34303841
[TBL] [Abstract][Full Text] [Related]
58. Rheumatic manifestations of chikungunya: emerging concepts and interventions.
Suhrbier A
Nat Rev Rheumatol; 2019 Oct; 15(10):597-611. PubMed ID: 31481759
[TBL] [Abstract][Full Text] [Related]
59. Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro.
von Rhein C; Weidner T; Henß L; Martin J; Weber C; Sliva K; Schnierle BS
Antiviral Res; 2016 Jan; 125():51-7. PubMed ID: 26611396
[TBL] [Abstract][Full Text] [Related]
60. Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.
Roy CJ; Adams AP; Wang E; Plante K; Gorchakov R; Seymour RL; Vinet-Oliphant H; Weaver SC
J Infect Dis; 2014 Jun; 209(12):1891-9. PubMed ID: 24403555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
